Recruiting

Glucose Tolerance Test

Sponsor:

MemorialCare Health System

Code:

NCT04199676

Conditions

Gestational Diabetes

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Accepted

Interventions

Glucose tolerance test

Study Details

Brief summary:

The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered in the postpartum period will be accurate and will improve compliance with postpartum testing for gestational diabetics.

Conditions

Gestational Diabetes

Study ID

NCT04199676

Start date

Sep 1, 2020

Status verified date

Sep, 2025

Completion date

Dec 31, 2026

Anticipated

Primary completion date

Dec 31, 2026

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Pregnant or recently postpartum (postpartum day 0 or 1)
  • ≥ 18 years of age
  • Gestational age ≥34 weeks
  • A1 or A2 gestational diabetes

Exclusion Criteria:

  • Medical exclusion from completing glucose tolerance testing
  • Steroid administration within 10 days prior to enrollment
  • Chronic steroid use

Study Design

Enrollment

300 participants

Anticipated

Interventions and Outcome Measures

Arms

Intervention

75g glucose tolerance test to be administered during postpartum hospitalization

Interventions

Glucose tolerance test

Oral administration of a 75g glucose tolerance test during the postpartum hospitalization

Primary outcome measure

  • Accuracy of immediate glucose tolerance testing [ Time Frame: 6-12 weeks postpartum ]

Central Contacts and Locations

Central contacts

Alice Sherman-Bron, MD

(562) 997-8510alicebrown092@gmail.com

Locations

Long Beach Memorial Medical Center/Miller Children's and Women's Hospital

Recruiting

Long Beach, California, United States, 90806

Contacts

Alice Sherman-Brown, MD

562-997-8510alicebrown092@gmail.com

More Information

Sponsor

MemorialCare Health System

Last update posted

Sep 3, 2025

Last verified

Sep, 2025

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by MemorialCare Health System on 2025-09-03.